Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Response, safety data updated for cancer vaccine INO-3112 in HPV-associated HNSCC trial

May 23, 2016

Regen Biopharma starts preclinical development of universal donor immunotherapy

May 23, 2016

Eureka Therapeutics CAR-T therapy targeting antigen/MHC complexes to enter phase I

May 20, 2016

Pelican Therapeutics wins NCPD award for the development of TNFRSF25 agonists

May 20, 2016

FDA grants priority review to sBLA for Genmab 's ofatumumab

May 20, 2016

Chugai's novel T cell-redirecting antibody targets both CD3 and glypican-3

May 20, 2016

MacroGenics and Janssen enter collaboration and license agreement to develop MGD-015

May 20, 2016

FDA approves Tecentriq and complementary diagnostic for metastatic urothelial carcinoma

May 19, 2016

Ono Pharmaceutical enters into option agreement with IDAC Theranostics for IT-1208

May 19, 2016

Cancer immunotherapy uses T cells expressing inducible MyD88/CD40 and targeted T-cell receptors

May 18, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...